Related Experiment Video

Updated: Jun 7, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
11:36

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

Myeloculture in patients with cutaneous lichmaniasis under treatment

J ARANHA CAMPOS

    Revista Paulista De Medicina
    |October 29, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    LEISHMANIASIS/therapy

    More Related Videos

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
    06:57

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

    Published on: February 20, 2020

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
    11:36

    Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

    Published on: April 21, 2012

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
    06:57

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

    Published on: February 20, 2020

    Related Concept Videos

    Leishmaniasis01:30

    Leishmaniasis

    Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

    Articles linked to this work by shared authors, journal, and citation graph.

    Cetuximab-loaded self-assembled polymeric nanoparticles for the integrin-targeted therapy of glioblastoma.

    JCIS open·2026

    Unraveling berberine's multi-target mechanism in combating early-stage masld: a network pharmacology and in vitro study.

    Cytotechnology·2026

    Iteratively Designed Phospholipid-Targeted Supramolecular Sonosensitizers for Precision Treatment of Pulmonary Infections.

    Journal of the American Chemical Society·2026

    Cytokine fusion proteins for solid tumor therapy: mechanistic insights and clinical advances.

    Journal of hematology & oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us